Close Menu

NEW YORK – Newomics said on Tuesday that it has closed a $7.9 million Series B funding round.

The round was led by MSA Capital, with new investor LDV Partners and existing investors including the Berkeley Catalyst Fund and the Photon Fund also participating.

Berkeley, California-based Newomics said it will use proceeds from the round to further commercialize products based on its mass spec multinozzle emitter array (MEA) technology, grow its sales and marketing as well as customer support teams, and expand collaborations with mass spec vendors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Moderna says it would be able to quickly update its SARS-CoV-2 vaccine to address new genetic variants if needed, MIT's Technology Review reports.

Johnson & Johnson reports interim results from a Phase 1/2 study of its SARS-CoV-2 vaccine in the New England Journal of Medicine, according to Bloomberg.

Investigators from the World Health Organization have arrived in China to look into the origins of SARS-CoV-2, NPR reports.

In Nature this week: a new method for high-throughput amplicon sequencing, and more.